ADBE
50
3
MA
60
5
M
40
3
PEP
33
4
SNA
56
3
DD
44
2
HST
53
4
GS
65
16
HP
44
14
EA
41
3
R
55
-2
SYK
50
4
L
54
5
NKE
36
2
TRV
34
4
AMP
43
2
V
70
14
SRE
37
9
BAX
38
2
TAP
57
6
ADBE
50
3
MA
60
5
M
40
3
PEP
33
4
SNA
56
3
DD
44
2
HST
53
4
GS
65
16
HP
44
14
EA
41
3
R
55
-2
SYK
50
4
L
54
5
NKE
36
2
TRV
34
4
AMP
43
2
V
70
14
SRE
37
9
BAX
38
2
TAP
57
6
Financhill
Back

Bioage Labs 10K Form

Sell
36

BIOA
Bioage Labs

Last Price:
$5.95
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIOA News And Ratings

See the #1 stock for the next 7 days that we like better than BIOA

BIOA Financial Statistics

Sales & Book Value

Annual Sales: $14.9M
Cash Flow: $-15.8M
Price / Cash Flow: 0
Annual Sales: $-6.38
Price / Book: 0

Profitability

EPS (TTM): -1.77420
Net Income (TTM): $-54.8M
Gross Margin: $-7.4M
Return on Equity: 0%
Return on Assets: 0%

Bioage Labs Earnings Forecast

Key Bioage Labs Financial Ratios

  • The Gross Profit Margin over the past 5 years for BIOA is -49.40%.
  • The Selling, General & Administrative Expenses for BIOA have been equal to 95.65% of Gross Profit Margin.
  • The Interest Expense is -12.21% of Operating Income.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Bioage Labs Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BIOA
CUSIP: 09072Q
Website: bioagelabs.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIOA Technical Analysis vs Fundamental Analysis

Sell
36
Bioage Labs (BIOA) is a Sell

Is Bioage Labs a Buy or a Sell?

  • Bioage Labs stock is rated a Sell
    The current Bioage Labs [BIOA] share price is $6.20. The Score for BIOA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.